Abstract This paper aims to provide researchers with practical information on sample sizes for accurate estimations of therapist effects (TEs). The investigations are based on an integrated sample of 48,648 patients treated by 1800 therapists. Multilevel modeling and resampling were used to realize varying sample size conditions to generate empirical estimates of TEs. Sample size tables, including varying sample size conditions, were constructed and study examples given. This study gives an insight into the potential size of the TE and provides researchers with a practical guide to aid the planning of future studies in this field.
Although the central role of therapists within the process of psychotherapy is obvious, the contribution of the individual therapist to the variability in treatment outcomes has often been neglected in study designs and analysis (Baldwin and Imel 2013; Beutler et al. 2004; Garfield 1997; Lutz and Barkham 2015) . Ricks (1974) reported the first empirical evidence for existing differences between therapists in his ''Supershrink'' study and the body of literature attesting to differences between therapists has steadily grown (for a review, see Baldwin and Imel 2013) . Based on a narrative review, Lambert (1992) attempted to attribute outcome in psychotherapy to various factors including the patient, the type of therapy and the specific therapist. The results emphasized the importance of the therapist variable to patient outcome and stimulated further investigations. Crits-Christoph et al. (1991) reported the first metaanalysis of therapist effects (TEs) and reanalyzed data from 15 studies and 27 treatment groups extracting an overall TE of 8.6 % (Crits-Christoph et al. 1991) . Twenty years later, in their review of TEs, Baldwin and Imel (2013) conducted a meta-analysis with more than twice as many studies (n = 46) that showed approximately 5 % of the variance in outcomes to be attributable to therapists. However, the percentage differed as a function of research design with only about 3 % of the variance associated with the person who delivered the treatment occurring in randomized controlled efficacy studies, but 7 % in naturalistic study designs. The utilization of manuals appears to reduce the variance associated with therapists, but there is a debate as to how much reduction in the size of TEs can be explained by the standardization of treatments utilizing manuals (Baldwin and Imel 2013; Crits-Christoph et al. 1991; Hofmann and Barlow 2014) .
The extant literature would therefore indicate that therapists differ in their effectiveness, that these differences are A previous version of this paper was presented at the 46th International Meeting of the Society for Psychotherapy Research (SPR), June, 2015, Philadelphia, USA.
& Anne-Katharina Schiefele schiefele@uni-trier.de small (depending on the study design) and that they seem-at least in naturalistic samples-to be reliable. This situation is to be expected, since, in a naturalistic situation, variability in therapist skills would be a natural phenomenon. Besides these relatively homogeneous findings in meta-analyses, the estimated proportion of variance that is attributable to therapists varies enormously between individual studies and samples. This becomes obvious in the meta-analysis reported by Baldwin and Imel (2013) , where the estimated proportion of variance that is attributable to therapists varies between 0 and 50 %.
Research has not focused on the reasons for this variability in TEs across naturalistic studies. However, it might partly be explained by small sample sizes leading to distorted results. The question remains as to how much sample size issues contribute to this heterogeneity in comparison to real variations in outcomes between therapists. Since the emergence of multilevel modeling (MLM), it has become the standard method for investigating TEs (e.g. Adelson and Owen 2012; Okiishi et al. 2006) . This method, which models the hierarchical structure of the data, with patients 'nested' within therapists, derives a TE that corresponds to the intraclass correlation coefficient (ICC) (see Raudenbush and Bryk 2002) . Hence, the accuracy and reliability of model parameter estimates and therefore the robustness of TEs, depends on the sample size. In the standard two-level multilevel model, three sample size parameters are relevant: the number of patients (Level 1), the number of therapists (Level 2) and the number of patients treated by each therapist. Because of these three different parameters, it becomes clear that sample size calculations that have been developed for traditional single-level designs cannot be applied to MLM.
Studies of sample size for cluster randomized trials (CRTs), where groups of subjects, rather than individuals, are randomized (Eldridge et al. 2006) , have recognized the problem of ignoring the hierarchical structure and the 'group effect' (i.e. the elevated risk of type 2 errors). In response, methods and formulas have been developed that take into the 'group effect' when making sample size calculations (e.g. Gao et al. 2015; Moerbeek 2014; Shoukri et al. 2004 ). However, these methods rely on a reliable a priori estimate of the group effect which in psychological therapies, given the heterogeneity of TEs above, is uncertain and still open to discussion. One example as to how an inadequate sample size can result in very different TEs is the reanalysis of the National Institute of Mental Health Treatment of Depression Collaborative Research Program (NIMH TDCRP; Elkin et al. 1989 ). This study was originally designed to investigate the effectiveness of two forms of brief psychotherapy (cognitive behavior therapy and interpersonal psychotherapy) in comparison to a pharmacotherapy and placebo condition. The sample contained 17 therapists who treated between 4 and 11 patients each. Using the same sample, Elkin et al. (2006) could not find variance associated with therapists, whereas Kim et al. (2006) identified a TE of approximately 8 %. The small sample size, along with other issues, has been identified as a cause of these contrary results (Crits-Christoph and Gallop 2006; Elkin et al. 2007; Lutz and Barkham 2015; Wampold and Bolt 2006) .
To date, sample size issues of MLM have been approached via simulation studies that result in formulating different guidelines regarding minimum sample size. Some researchers suggest a minimum sample size of 30 groups on level 2 (therapists) and 30 units per group on level 1 (patients) to have enough power in a two-level design (Kreft 1996) . Maas and Hox (2005) argue that a major restriction in MLM is higher-level sample size. In a simulation study, they showed that samples of 100 generic clustering units led to unbiased estimates of variance components and standard errors. In their study, a large number of level 2 units appeared to be more important than the number of units on level 1. The lowest group size included in the simulation analyses was 5 units on level 1, which resulted in unbiased estimations if enough units on Level 2 were included in the samples.
Some researchers incorporate an alternative perspective that draws attention to the focus of the research question (Hox 2010; Raudenbush and Bryk 2002) . If the investigation aims to analyze random effects, Hox (2010) recommends applying a 100/10 rule: 100 therapists on level 2 and a group size of 10 patients per therapist resulting in a sample of 1000 cases. If cross-level interactions are of interest, the equivalent recommendation is a 50/20 rule: 50 therapists treating 20 patients each, which results, again, in a sample of 1000 cases. Other research has focused on the power within three-level longitudinal models with repeated measures on level 1, patients on level 2 and therapist on level 3. Based on a simulation study, De Jong et al. (2010) provide recommendations concerning different sample size combinations for all three levels to reach a power of 0.80.
In summary, the above mentioned simulation studies supply researchers with inconsistent rules of thumb with relatively high average sample sizes on each level. So far, very few research studies have been able to realize these sample size demands (e.g. Saxon and Barkham 2012) . Nonetheless, several studies have at least approximately reached tolerable sample sizes (e.g. Dinger et al. 2008; Lutz et al. 2007; Okiishi et al. 2003) with an average of 55 therapists per dataset, who treated at least 10 patients each, resulting in samples ranging from N = 1779 to N = 2554 cases. However, in Baldwin and Imel's (2013) review, 43 out of 46 studies can be classified as having serious sample size problems. The median number of therapists within these studies was 9 with a median of 7.6 patients per therapist. In contrast to these ''real-world'' findings, a simulation study by Musca et al. (2011) did not even include groups smaller than ten cases. However, in naturalistic samples it is common to have therapists with fewer than ten treated patients (see Baldwin and Imel 2013) .
Due to the reported variability in the size of TEs and the apparent influence of sample sizes, the main aim of the present study was to develop empirical estimates of TEs for varying sample size conditions and to explore sample size factors, which may affect their magnitude as well as their stability. First, we individually examined eight naturalistic datasets regarding the extent of TEs, while controlling for initial impairment in therapist caseloads. In line with the existing literature, we expected to find substantial differences in TEs between datasets, but with all of them showing significant TEs. After standardization and integration into one sample, we anticipated finding an average significant TE of about 5 %.
Second, we developed sample size tables for future research via resampling. The aim was to provide practical information to aid the planning of future studies in this field and to complement simulation work on providing sample size guidelines in multilevel analyses of TEs.
Method Original Datasets
The study sample included eight datasets drawn from 3 countries (US, UK and Germany), including 6 different outcome measures routinely collected between 1990 and 2013 and cumulating in aggregated data from 48,648 cases treated by 1800 therapists. All individual datasets complied with local ethics committee approvals where necessary. In the following section, the eight international samples are described individually.
The University Outpatient Clinic sample from southwestern Germany comprised 668 psychotherapy outpatients and 97 therapists who each saw between 2 and 18 patients (M = 8.78, SD = 3.70). Therapists were all part of a Cognitive Behavioral Therapy (CBT) based postgraduate training program. Patients attended between 3 and 98 sessions (M = 33.46, SD = 17.31). The patients' mean age was 36.35 (SD = 12.49; range 15-74); 70.3 % were women; 40.1 % had a primary diagnosis of major depressive disorder, 18.7 % were diagnosed with anxiety disorder, 16.6 % had an acute stress and adjustment disorder, 5.8 % had a dysthymic disorder, 4.0 % an eating disorder, 1.2 % were diagnosed with a personality disorder, and 13.4 % were classified with another psychological disorder. The Brief Symptom Inventory (BSI; Franke 2000) was used as the primary outcome measure.
The Techniker Krankenkasse sample was based on a health insurance pilot project that investigated quality management in outpatient psychotherapy in Germany between 2005 and 2010, supported by the German health insurance company Techniker Krankenkasse (TK; Lutz et al. 2011) . A subsample of the TK-project was used in this paper. It comprised 636 psychotherapy outpatients and 120 therapists who saw between 2 and 18 patients each (M = 8.31, SD = 4.94). Therapists were from different theoretical orientations: 69.8 % had a CBT background, 34.9 % were trained in psychodynamic psychotherapy, whereas 3.1 % had a psychoanalytic orientation (multiple answers possible). Patients attended between 5 and 143 sessions (M = 35.66, SD = 20.86). The patients' mean age was 45.06 (SD = 11.30; range 21-77); 68.2 % were women and 97.2 % were German. 38 % had a major depressive disorder, 21.2 % were diagnosed with an acute stress and adjustment disorder, 19.2 % had an anxiety disorder, 7.1 % had a dysthymic disorder, 2.4 % were diagnosed with an eating disorder, 2.2 % with a personality disorder and 10 % were classified with another psychological disorder. For the TK project, the BSI was also one of the primary outcome measures (Franke 2000) .
The University Outpatient Clinic in Midwest Germany sample comprised 752 patients treated by 71 therapists. Therapists were either trained or part of a post-graduate training program with CBT as their theoretical orientation. Each therapist treated between 2 and 26 patients (M = 13.02, SD = 4.91). Patients attended between 4 and 90 sessions (M = 30.62, SD = 17.72). The patients' mean age was 37.29 (SD = 11.71; range 16-74); 56.9 % were women; 44.9 % were diagnosed with an anxiety disorder, 22.1 % had a major depressive episode, 8 % had an acute stress and adjustment disorder, 6.6 % were diagnosed with an eating disorder, 3.4 % had a dysthymic disorder, 1.9 % were diagnosed with a personality disorder, and 12.9 % were classified with another psychological disorder. Like the other German samples, the BSI (Franke 2000) was used as the primary outcome measure in this dataset.
The CelestHealth dataset was based on data from 26 centers comprising 20 college counseling centers, four primary care medical centers, and two private mental health centers located in the US. The sample comprised 11,356 patients treated by 401 therapists. Each therapist treated between 2 and 203 patients (M = 63.74, SD = 43.94). Therapists included psychologists, psychiatrists, clinical social workers, and trainees, all reflecting a varied professional background and theoretical orientation. Furthermore, treatment duration was variable and not subject to strict time limits so that patients attended between 3 and 154 sessions (M = 8.66, SD = 8.90). All patients were older than 18 years and a majority were female (63.5 %). No information on diagnosis was available for this sample. The primary outcome measure was the Behavioral Health Measure-20 (BHM-20; Kopta and Lowry 2002) .
The Compass Tracking System, originally called Integra Outpatient Treatment Assessment system (IOTA; Howard et al. 1996; Lueger et al. 2001; Lyons et al. 1997) , is a quality monitoring system and one of a number of comprehensive assessment batteries that has been used to measure progress in outpatient mental health. The dataset gathered with the assistance of the Compass System comprised 1194 psychotherapy outpatients who were treated by 60 therapists in different settings in the US (Lutz et al. 2007 ). Therapists were part of the national provider network of an American managed care company. All therapists had formal training and at least 1 year post qualification experience. They varied in professional background and theoretical orientation that was not systematically recorded. Each therapist treated between 10 and 77 patients (M = 28.79, SD = 19.50). Treatment duration was not subject to strict limits so that patients attended between 3 and 120 sessions (M = 9.60; SD = 10.49). The patients' mean age was 36.40 (SD = 9.50); 73 % were women; 59 % were married, 24 % were single, and 18 % were separated, divorced, or widowed; 43.9 % were diagnosed with an affective disorder, 28.4 % had an acute stress and adjustment disorder, 8.8 % had an anxiety disorder, 0.8 % were diagnosed with an eating disorder, 4.7 % had another psychological disorder and for 13.4 % of the cases, the diagnosis was missing. The primary outcome measure of the Compass Tracking System was the Mental Health Index (MHI; Howard et al. 1993b) .
The University Counseling Center dataset was collected at a large site in the US. It comprised 2561 patients treated by 143 therapists. All of the therapists were doctoral level students in training or doctoral licensed mental health professionals. They had a variety of treatment orientations, with most integrating two or more theoretical systems (e.g. cognitive and behavioral). Each therapist treated between 2 and 155 patients (M = 56.30, SD = 47.38). Patients attended between 3 and 102 sessions (M = 8.50; SD = 8.21). The patients' mean age was 31.84 (SD = 5.12; range 21-74); 58.6 % were women and 91.9 % were American. 17.3 % were diagnosed with an affective disorder, for 7.7 % the diagnosis was deferred, 7.5 % had an acute stress and adjustment disorder, 5.9 % were diagnosed with an anxiety disorder, 2.6 % had an eating disorder, 0.3 % were diagnosed with a personality disorder, 5.2 % had another psychological disorder, whereas 31.2 % had no psychological disorder and 22.3 % no diagnosis at all. The primary outcome measure was the Outcome Questionnaire-45 (OQ-45; Lambert 2004) .
The Clinical Outcomes in Routine Evaluation (CORE) Practice-Based Evidence National Database-2008 comprised 25,842 patients treated by 789 therapists in counseling and psychotherapy centers in the United Kingdom between 1999 and 2008. All therapists had training in psychological therapy and at least 1 year post qualification experience. Furthermore, a variety of treatment approaches were offered, whereas none of the therapists consistently followed a formal manualized protocol. Each therapist treated between 2 and 400 patients (M = 103.31, SD = 87.21). Patients attended between 3 and 117 sessions (M = 6.83; SD = 4.37). The patients' mean age was 40.27 (SD = 11.93, range 16-65); 71.3 % were women. No formal diagnosis was recorded. Nevertheless, therapists identified patients' presenting problems. This indicated that 70.8 % were experiencing depression, 42.1 % at a moderate to severe level, while 78.4 % were experiencing anxiety, 55.5 % at a moderate to severe level. The primary outcome measure of this sample was the Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM; Barkham et al. 2001; Evans et al. 2002) .
The Improving Access to Psychological Therapies (IAPT) dataset comprised 5639 patients treated by 119 therapists and was collected in North England between 2008 and 2010. Therapists in this sample included qualified CBT practitioners delivering high intensity psychotherapy (up to 20 sessions), registered mental health nurses, counsellors, and psychological well-being practitioners (PWPs) delivering low intensity and brief (less than 8) CBT-oriented guided self-help interventions. Treatments were delivered in a stepped care system, with the majority of patients accessing brief interventions and progressing to high intensity psychotherapy if required, as recommended by English clinical guidelines (National Institute for Health and Care Excellence 2011). Each therapist treated between 2 and 163 patients (M = 80.14, SD = 42.60). Patients attended between 3 and 21 sessions (M = 6.63; SD = 3.81). Patients' mean age was 39.06 (SD = 13.54, range 16-98). The majority of patients were women (65.4 %); 30.4 % were diagnosed with an affective disorder, 22.9 % had a mixed anxiety and depression disorder, 19 % had an anxiety disorder, 2.2 % were diagnosed an obsessive-compulsive disorder, 1.4 % had an acute stress and adjustment disorder, 0.8 % had an eating disorder, 23.2 % had another psychological disorder, and 22.3 % no diagnosis at all. The relevant outcome measure in the IAPT dataset was the Patient Health Questionnaire (PHQ-9; Kroenke et al. 2001 ), self-completed by patients on a session-by-session basis.
Instruments
Brief Symptom Inventory (BSI; Franke 2000; German translation of Derogatis 1975) . The BSI is a 53-item selfreport symptom inventory for the evaluation of physical and psychological symptoms within the last week. It is the brief form of the Symptom Checklist-90-R (SCL-90-R; Derogatis 1977) . The instrument taps 9 primary dimensions: somatization, obsessive-compulsive, interpersonal sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideation and psychoticism. In this study, only the Global Severity Index (GSI) was calculated by averaging all items. The items are scored on a 5-point Likert scale ranging from 0 (not at all) to 4 (extremely). The internal consistency of the BSI has been found to be a = 0.92 and the retest-reliability r tt = 0.90 (Franke 2000) .
Behavioral Health Measure-20 (BHM-20; Kopta and Lowry 2002) . The BHM-20 is a 20-item self-report questionnaire for the evaluation of mental health. The instrument comprises three subscales: well-being, psychological symptoms and life functioning. The Global Mental Health Index (GMH) was used for the present paper, which is calculated by averaging the 20 items. Clients rate the items on a Likert scale ranging from 0 (extreme distress/poor functioning) to 4 (no distress/excellent functioning). The scales were adjusted so that higher scores indicated more psychological distress. The internal consistency of the BHM has been found to be a = 0.89 to 0.90 and the retestreliability r tt = 0.80 (Kopta and Lowry 2002) .
Mental Health Index (MHI; Howard et al. 1993b ). Within the Compass Tracking System, a patient's progress in outpatient treatment was measured based on three scales capturing both their own as well as the clinician's perspective (Howard et al. 1993b ). The present study focused on the scales capturing the patient's perspective, which comprised 68 items. The three scales subjective well-being, current symptoms and current life functioning are in line with the three phases of the phase theory of psychotherapy: remoralization, remediation and rehabilitation (Howard et al. 1993a ). The three scales are combined into a Mental Health Index (MHI) that was used in the current analyses with higher scales indicating more psychological distress. The internal consistency of the MHI has been found to be a = 0.88 and the test-retest correlation r tt = 0.82 (Howard et al. 1993b ). The scales were adjusted so that higher scores indicated more psychological distress.
Outcome Questionnaire-45 (OQ-45; Lambert 2004). The OQ-45 is a self-report instrument that captures mental health functioning over the course of the last week. The questionnaire can be administered at the beginning as well as over the course of treatment to track and measure client progress in psychotherapy. The 45 items are scored on a five-point Likert scale ranging from 0 (never) to 4 (almost always), resulting in a range of possible scores from 0 to 180. Besides the global sum score, the OQ-45 comprises three subscales: symptom distress, interpersonal functioning and social role functioning. In this study, the total score was utilized so that higher scores indicated more symptom severity. Internal consistency reliabilities have been found to vary from a = 0.70 to 0.93 for the total scale and subscales. Test-retest reliabilities range from r tt = 0.78 to 0.84 (Lambert 2004; Lambert et al. 1996) .
Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM; Barkham et al. 2001; Evans et al. 2002) . The CORE-OM is a self-report measure comprising 34 items addressing four different domains: well-being, symptoms, functioning and risk. Items are scored on a 5-point Likert scale from 0 to 4 anchored by the following terms: not at all, only occasionally, sometimes, often and all or most of the time. A global score is calculated as the mean of all completed items multiplied by 10, yielding a range from 0 to 40 with higher scores indicating more symptom severity. The internal consistency of the CORE-OM has been found to range from a = 0.93 to 0.95 with a test-retest reliability of r tt = 0.90 (Barkham et al. 2001; Evans et al. 2002) .
Patient Health Questionnaire-9 (PHQ-9; Kroenke et al. 2001) . The PHQ-9 comprises items drawn from the primary care evaluation of mental disorders (PRIME-MD), which has been validated for use in primary care. The 9-item depression scale used in this paper captures depression corresponding with DSM-IV criteria as well as general symptom severity. Items are rated on a scale ranging from 0 (not at all) to 3 (nearly every day). For the purpose of this paper, the global sum score was calculated ranging from 0 to 27. The internal reliability of the PHQ-9 has been found to be a = 0.89 and its validity has been shown in a variety of settings and populations (Kroenke et al. 2001; Manea et al. Manea et al. 2012 ).
Data Prescreening and Standardization
All data included in the analyses were prescreened concerning the following criteria: (a) individual patient data comprised pre-and post-therapy measures on the appropriate outcome instrument; (b) a unique ID was available for each therapist; (c) each therapist treated a minimum of two patients; and (d) each case comprised at least 3 sessions.
Moreover, as described previously, six different instruments were used to assess outcome across the eight samples. For this reason, a standardization procedure was necessary to integrate the subsamples into one large dataset. The most common method for standardization is to perform a z-transformation, where the sample mean is subtracted from each score and the difference is divided by the sample standard deviation. Although the eight samples were routinely collected, the level of patient impairment cannot be presumed to be equal across institutions, datasets, and countries. A normal z-transformation would not take these distinctions into account and, moreover, this procedure might confound the size of the TE. We reasoned that standardizing each individual dataset on the mean and standard deviation of an appropriate measure-specific outpatient reference sample drawn from current psychotherapy research would obviate this potential confound. Hence, for each of the six instruments, the mean and standard deviation of a clinically impaired population were identified. Using the resulting reference values, the pre and post scores of the associated datasets were standardized. Subsequently, all eight datasets were integrated into one large dataset that represented the basis for the following analyses.
Data Analytic Strategy
All eight samples contained a hierarchical data structure, for which multilevel modeling (MLM) has been established as the method of choice (Hox 2010; Raudenbush and Bryk 2002) . To analyse the TE and its variation in each of the eight samples, two-level models were calculated with patients at level 1 and therapists at level 2 (equations are reported in the Appendix). The two-level model partitions the total variability into two components: variance within patients at level 1 and between therapists at level 2. The variance associated with level 2 divided through the total variance is the TE (Baldwin and Imel 2013) . All models that were used to calculate the TE included pre-treatment intake scores on the relevant outcome measure to control for individual differences in pre-test levels. This variable was standardized as described above and therefore all TEs were estimated for the average initial patient severity. In all models, division of level 2 variance through total variance resulted in intraclass correlation (ICC), which is a synonym for the TE (Hox 2010) . The higher the ICC, the larger the differences between therapists concerning the outcome variable of interest: patient outcome. Furthermore, we tested the possibility of a random slope model for all eight datasets, where the relationship between pre-treatment scores and outcome was allowed to vary between therapists. The Akaike information criterion (AIC) was used to investigate which model fit the data best, whereas smaller values indicate a better model fit (Hox 2010 ).
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In a next step, after integrating the eight samples into one dataset, a three-level hierarchical model was conducted with patients at level 1, therapists at level 2 and datasets at level 3 (equations are reported in the Appendix). The threelevel model partitions the total variability in outcome into three components: variance within patients on level 1 (r 2 ), between therapists on level 2 (s p ), and between datasets on level 3 (s b ). As in the two-level model, the variance associated with level 2 yields the TE and was calculated using the ICC corrected for initial patient severity. Again, a random slope model was considered, where, once more, the AIC served as the fit criterion. The variance associated with level 3 represents the dataset effect. Although eight units at level three is not sufficient to reliably interpret the dataset effect, we included the third level because the analyses of the eight individual datasets revealed a large variation in TEs. By including the third level in the model, these dataset differences could be extracted from the total variance, allowing the estimate of the TE to become more precise.
Investigation of Sample Size Issues
The investigation of sample size issues in relation to the extent and reliability of TEs was achieved by examining different sample size conditions. A basic subsample was formed comprising only therapists who treated a minimum of 30 patients. This resulted in a core subsample of 484 therapists (patient N = 36,263). In reducing the number of therapists and the number of patients per therapist, different sample size conditions were produced. For each sample size condition, 1000 samples were randomly selected out of the existing core subsample. This allowed us to estimate the mean TE across 1000 samples for each sample size condition. Furthermore, confidence intervals (CIs) were computed, which were used as indices of precision for the estimated mean TEs. The reference for the width of the CIs was based on the results of the two existing meta-analyses in this research field. These two studies estimated TEs between 5 and 9 % resulting in a range of 4 % (Baldwin and Imel 2013; Crits-Christoph et al. 1991) . On this basis, we decided to allow the CIs in our study to have a maximal range of 4 %.
We reduced the number of therapists in intervals of 100 (400, 300, 200 and 100) and then from 50 the number of therapists decreased in intervals of 10 (50, 40, 30, 20 and 10) . As soon as the number of therapists per dataset was reduced to 10, the reduction scheme changed and specified only 5 and then 2 therapists per dataset. In line with this, the number of patients per therapist was reduced starting with only those therapists that treated 30 patients. First, the reduction was implemented at intervals of 5 (30, 25, 20, 15, 10 and 5) and then in single steps (5, 4 and 3). Finally, sample size tables were generated that included information about mean TEs and CIs for each sample size condition. A total of 72 sample size conditions were computed.
As a result of the resampling procedure described above, two new variables were generated: mean TE per sample size condition and its CI. Each of the two variables served as an outcome variable in a multiple regression analysis that was conducted to investigate the influence of number of patients per therapist as well as number of therapists per dataset.
All data analyses were conducted with the free software environment R version 3.1.0 (R Development Core Team 2014). For MLM, the package lme4 was used (Bates et al. 2013 ) whereas parameters were estimated via maximumlikelihood (ML) and p values were calculated using lmerTest (Kuznetsova et al. 2014) .
Results

Variability Across Datasets
The AIC revealed that a random intercept model had a better fit in the analyses of all eight datasets than a single level regression model, thereby indicating significant variability between therapists (level 2) even after adjusting for initial patient impairment. The two-level analyses revealed variability in TEs and effect sizes between the eight datasets (Table 1) . TEs varied between 2.7 % (IAPT dataset) and 10.2 % (CORE Practice-Based Evidence National Database 2008) whereas effect sizes ranged between 0.49 (University Counseling Center in the UK) and 1.45 (CORE Pratice-Based Evidence National Database 2008). These heterogeneous results must be interpreted with care, based on the knowledge of dataset differences concerning treatment process (Completer vs. non-completer sample; see Table 1 ). Averaging the eight individual TEs led to a mean TE of 5.7 %.
2 Furthermore, the random slope model improved model fit in all samples regarding the fit criterion AIC. This suggested significant variability between therapists concerning the relationship between pre-treatment scores and outcome. Additionally, therapist variation of baseline estimates was investigated. Across the eight datasets a mean between therapist variation of 4.3 % was detected. It ranged from 0.4 % in the University Outpatient Clinic sample from southwestern Germany to 11.3 % in the German TK sample.
Three Level Hierarchical Analyses for the Total Dataset
The results for the aggregated dataset are displayed in Table 2 . Initial patient impairment was a significant predictor and explained 25.3 % of the variation in outcome.
Dividing level 2 variance (therapist variation) by the total variance in model 1 led to a significant TE of 6.7 %. Thus, most of the variation in outcomes (87.1 %) was at the individual patient level (level 1). Again, including a random slope improved model fit regarding the AIC, suggesting that there were considerable differences between therapists regarding the relationship between initial impairment and treatment outcome. Comparing the residuals and 95 %-CIs of each therapist with the average therapist outcome, we identified which therapists were above or below that average. This resulted in 225 therapists (12.5 %) out of 1800 who were identified to be above average in terms of the outcomes of their patients and 11.8 % (N = 212) of the therapists who were below average. Consequently, 1363 therapists (75.7 %) were ranked as average regarding the outcome of their patients and could not be reliably differentiated from each other.
Investigating Sample Size Issues
The results of the resampling procedure are presented in Table 3 . 3 For each of the 72 sample size conditions, the mean TE as well as its CI were calculated within three-level hierarchical models allowing slope and intercept to vary between therapists (see Appendix). The mean TEs and associated CIs were used as outcome variables in two individual multiple regression analyses that were run to evaluate the impact of sample size parameters. First, the influence of number of patients per therapist and therapists per dataset as well as their interaction on the mean TE were computed. The two predictor variables and their interaction were significant, F(3, 135) = 33.90, p \ 0.001 (Table 4 ) and explained 43.5 % 4 of the variance in TEs. A second multiple regression was conducted to predict the range of the CIs. Again, covariates were significant F(3, 135) = 50.99, p \ 0.001 and explained 53.7 % (see footnote 4) of the variation in the range of CIs.
Visual representations of the resampling procedure are given in Figs. 1 and 2 . These figures illustrate the influence of the two sample size parameters on the magnitude of TEs (Fig. 1 ) and the width of CIs (Fig. 2) .
Application
The aim of these analyses was to provide researchers with guidance on sample sizes for an accurate estimation of TEs. We suggest interpreting the results in two consecutive steps. First, researchers should start with Fig. 1 , which depicts the mean TE for each sample size condition. As reference for an 2 Because of the nested data structure, three sample size parameters must be considered when weighting the arithmetic mean: (1) number of patients (2) number of therapists (3) number of patients per therapist. The mean TE weighted for the number of patients is 7.2 %, the mean TE weighted for the number of therapists is 7.1 and 5.75 % if the mean TE is weighted by the mean number of patients per therapist.
3 Due to shortage of space and clarity, not all sample size conditions are displayed in Table 3 . 4 The explained variance (R 2 ) was calculated in accordance with the recommendations of Hox (2010) . empirical TE, we used the 6.7 % TE from the present study. After deciding on a sample size that meets the reference TE, a researcher should check if this sample is sufficient to result in a reliable TE. Second, in Fig. 2 the width of the CIs per sample size condition are presented, which can be used as a measure for the precision of the estimation. The smaller the differences between the upper and the lower bound of the CI, the more reliable the computed TE.
Assume that in the planning phase of a naturalistic study, the aim is to investigate the TE in an outpatient clinic. A total of 10 therapists have been recruited to join the study and the question is: are 10 therapists sufficient to precisely estimate TEs? In the first step, Fig. 1 indicates that each of these 10 therapists needs to treat at least 10 patients to reach the reference TE. After deciding on a sample size that meets the reference TE (see Fig. 1 ), a researcher should also check if this sample is sufficient to result in a reliable TE (see Fig. 2 ). In this case, Fig. 2 indicates that 10 therapists at level 2 is not recommended, as the CI exceeds 4 % (CI difference = 12.27 %; Table 3 ), thereby yielding an unreliable estimation. In this case, the number of patients per therapist cannot compensate for the small number of therapists at level 2. Hence, the study requires a further 30 therapists (N therapist = 40). Additionally, the number of patients per therapist must be increased to 30 in order to reach a sample size that more precisely estimates the TE (Fig. 2) . This example indicates that minimum sample sizes at both levels are necessary. But given the minimum sample size at each level, Figs. 1 and 2 also show that sample size limits at one level can be partially compensated by those at the other level.
In the context of minimum sample sizes on both levels, Fig. 1 shows that a sample to investigate TEs should have at least 4 patients per therapist. With smaller group sizes than 4 the TE will be overestimated, although the CI is within the reference range (Fig. 2) . It should be noted that with a group size of 4 cases, the sample needs to include at least 300 therapists, yielding a sample of 1200 patients. With regard to level 2, at least 40 therapists per sample are needed in order to be able to estimate the TE reliably. Again, it should be highlighted that in a sample with 40 therapists, each therapist needs to treat at least 30 cases thereby leading to a sample of 1200 patients.
Discussion
Twenty-five years ago, Kazdin and Bass (1989) raised the question concerning the extent to which comparative outcome studies are adequately powered in the field of psychotherapy outcome research. Their findings suggested that most of the studies that compared alternative treatments were insufficiently powered to detect small-to-medium effect sizes. However, at the time, investigations of large naturalistic datasets were rare. By contrast, the collection and investigation of large datasets is increasingly commonplace in current research communities. In response, we consider that the question of statistical power and reliability of estimates can be raised in a different context regarding studies investigating TEs in practice. The question we examined is whether sample sizes of psychotherapy outcome studies are sufficiently large to reliably detect differences between therapists, if they exist.
Estimates of sample sizes required in studies of TEs have been addressed using simulation studies (e.g. Bell et al. 2014; Maas and Hox 2005) . These studies have delivered inconsistent results and corresponding rules for sample sizes at each level of the MLMs. In addition, this guidance often does not reflect the sample structure in research studies. In view of the above, the present study is the first empirical investigation of sample size issues focusing on MLM and TEs in the context of naturalistic study designs. To date, no study has estimated the TE in a naturalistic sample with such a large sample size (N = 48,648). This is important, considering its implications for interpreting the percent of variance in outcome that can be attributed to patients and treatments.
Practical sample size tables for calculating TEs were the result of the investigation of eight naturalistic datasets and resampling procedures. These can be utilized to identify minimum samples sizes in future practice-oriented studies focusing on TEs. The values in the tables reveal that there is a degree of flexibility in the numbers of therapists and patients per therapist required, depending on the approximated CI. For example, a variable number of therapists and patients per therapist is possible as long as an overall sample size of 1200 patients is achieved, which allows for an estimated TE within a CI lower or equal to 4 %. This means that at least 4 patients per therapist with 300 therapists or at least 40 therapists treating 30 patients are necessary to render sufficiently accurate parameter estimates. This number is consistent with the existing literature on simulation studies using MLM, which suggest an overall sample size of approximately 1000 cases (e.g. Hox 2010; Raudenbush and Bryk 2002) . The sample size of 1200 cases highlights the limitations that occur within small services that try to analyse TEs. Prospectively, nation-wide services and systems rather than small services will provide sufficiently large datasets to overcome sample size limitations. One example is the IAPT program in England, which is a government funded initiative to offer patients routine psychological treatment. Within this program, data is collected and merged from all affiliated services, resulting in a large and expanding database, which also provided a dataset for the current analyses. More such national practice networks would advance research possibilities in the context of TEs.
Crucially, the present study also investigated the consequences of samples comprising small numbers of therapists as well as samples with small numbers of patients per therapist. Attempts to bridge the scientist-practitioner gap are hindered where the research demands placed on routine services are unrealistic. Hence, sample size guidelines were formulated for small numbers on level 1 (patients per therapist), which seem to be realistic to obtain in routine care datasets. Results are displayed in easy-to-read sample size tables, which can be flexibly applied by researchers to evaluate the appropriateness of their assessment structure, if TEs are considered. Furthermore, the tables can be used to get a rough estimate of the potential CI related to existing samples. This can help to plan studies and/or to understand the heterogeneity in results between different studies. Obviously, guidelines for studying therapist effects drawn from routine care have implications for studying therapist effects in clinical trial research (recall the controversy ignited by the re-analysis of the NIMH TDCRP dataset discussed in the introduction). Given the small number of therapists and small number of patients per therapist in some clinical trials, therapist effects in such studies should be interpreted with caution. Furthermore, applying a multiple regression approach, we analyzed the impact of the number of patients per therapist as well as the number of therapists as predictor Elkin et al. 2006 Elkin et al. , 2013 Owen et al. 2010 ) while other studies have reported TEs of 10 % or higher (e.g. Boswell et al. 2010 ). Besides varying sample sizes, the descriptive heterogeneity of the datasets in this article might deliver an additional explanation for the inconsistent results regarding the size of TEs. This extended range held even when a standardization procedure based on the average impairment of a clinical reference sample was implemented to control for the impact of initial impairment. Initial patient severity was found to be a significant predictor in all naturalistic datasets as well as in the integrated total dataset, which replicates former research (Saxon and Barkham 2012) . Additionally, in all eight datasets we consistently found the random slope model to be significantly superior as compared to the fixed slope model. This result suggests that there are differences between therapists in all datasets regarding the relationship between pre-treatment and posttreatment scores, indicating variability between therapists in terms of how much intake severity impacts treatment outcome. The random slope model showed the best model fit in the three-level MLM, which further supports this interpretation. At the moment, we do not know why some therapists seem to be similarly effective, no matter how impaired patients are and why others are less effective in adapting to different initial impairment levels. This question warrants further research and has implications for training as well as practice.
After integrating the data into one large sample, our three-level MLM approach showed that about 6.7 % of the variance in outcome was explained by therapist differences. This was slightly higher than the 5.7 % TE that was calculated when simply averaging the TEs of the eight individual datasets. Hence, the hierarchical model enhanced the effect by correcting for level 3 influences. In sum, the size of the TE in the three-level MLM was comparable to the findings in the most recent meta-analysis in this field, which suggested that approximately 7 % of the variance in outcome was associated with therapists in naturalistic study designs (Baldwin and Imel 2013) . In addition, the distribution of therapist effectiveness was akin to that reported by Saxon and Barkham (2012) , although our data revealed approximately 10 % more therapists to be average.
The main limitation of the present study relates to the heterogeneity of the investigated samples and the outcome measures as well as the lack of consistent additional predictors that might explain variance associated with therapists. It is important to note that in the analyses, some datasets were considerably larger (CORE Practice-Based Evidence National Database 2008: N = 25,842) in comparison to others (TK-project: N = 363) and therefore contribute much more cases to the aggregated dataset. Therefore, we incorporated a third level in the MLM to correct for varying dataset influences. However, with only eight datasets available it was not possible to reliably estimate the impact of the third level or even to use predictors to try to explain dataset variance. More datasets would have allowed us to investigate the 'dataset effect' and potential further predictors (e.g. completer, non-completer, and number of sessions) of the heterogeneity in TEs besides sample size.
Although variations in sample sizes across datasets may partially explain the range of TEs in the current study sample, it is unlikely to be the only source of variability across datasets. Different clinical populations, therapists' backgrounds, intervention settings, case mix factors, etc. may have enhanced bias in the data. For example, the TE estimate in the IAPT dataset is very small despite an adequate sample size. Additionally, cultural differences as well as differences between countries' health care systems could have influenced bias. There are large differences between the US, UK and Germany concerning care systems, culture and therapist training. In summary, it must be mentioned that it was not possible to control for all sources of variability that may have impinged TE estimates, not only in the investigation of individual datasets, but also in the integrated study sample.
In addition to differences in datasets, the variety of outcome instruments may have also contributed to the heterogeneity of TEs. Instruments may differ in their ability to capture important variations in outcome and could therefore lead to different TEs. For example, Huppert et al. (2001) analyzed data from the Multicenter Collarborative Study for Treatment of Panic Disorder and found TEs ranging from 1 to 18 %, depending on the outcome measure in the field of anxiety disorders. Hence, there may be an impact of instruments on TE sizes. However, in the current sample, it was not possible to investigate this influence specifically, as measures were confounded with datasets as well as countries. Consequently, the results must be interpreted with care, based on the knowledge that datasets and instruments can hardly be disentangled. However, we incorporated a third level in the MLM to control for datasets. Furthermore, the standardization procedure allowed us to investigate the TE from an overall perspective. Nevertheless, further research should consider the impact of different instruments when interpreting and examining the heterogeneity of TEs between studies.
An additional limitation concerns the interpretation of sample size tables. The analyses were conducted for prepost models, which were corrected for initial impairment. This model has emerged to be the most applied model in TE research (Baldwin and Imel 2013; Saxon and Barkham 2012) . However, there is a broad range of more complex models in the field of multilevel modeling. Raudenbush and Bryk (2002) pointed out the more complex the model (e.g. more predictors), the larger the required sample sizes. In line with this, we must state that our results are limited to the pre-post model described above and that we cannot make any recommendations concerning more complex models. One example is growth curve models, which analyze nested longitudinal data with repeated patient measures on level 1 (e.g. Lutz et al. 2007 ). De Jong et al. (2010) dealt with sample size issues concerning these models within the evaluation of TEs. Moreover, results are constrained to maximum-likelihood estimations. Accordingly, other statistical approaches such as Generalized Estimating Equations (GEE) could have been used. However, in regard to the research question, multilevel modeling on the basis of maximum-likelihood estimations which focuses on the partition of variance associated with each level seemed to be the appropriate method (e.g. Burton et al. 1998; Gardiner et al. 2009 ). Furthermore, it is the most common approach for analyzing TEs (Baldwin and Imel 2013) .
Despite these limitations, this article provides researchers with real-world recommendations concerning sample sizes for optimal study designs when the aim is to analyse TEs in a pre-post design. In addition, CIs presented in this paper aid in the interpretation and evaluation of TEs within existing samples. Moreover, sample size tables provide researchers with a practical and easy to use tool for the future planning of studies examining TEs. As mentioned in the theoretical section, the accurate TE is still a subject of discussion in this research field. Accordingly, the paper is a contribution on the path of reaching consent. In this sense, the application of the paper could be to use the results as a priori estimates for analytic formulas to calculate sample sizes for future TE studies (for a review see Shoukri et al. 2004 ). In conclusion, the combination of sample sizes on each level is crucial for the accuracy of the investigation of TEs in practice-oriented research. Tables presenting different sample size scenarios might help researchers to improve study designs and to integrate the interpretation of results in this research area. There is much to be learned from studying therapists, whose treatment effects are well below or above average. Therefore, we encourage researchers to consider sample size as an important precursor to undertaking such analyses.
